Patents by Inventor Bo R. Rueda

Bo R. Rueda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and Methods for Targeting Cancer Stem Cells
    Publication number: 20240002537
    Abstract: Compositions and methods for treating ovarian cancer are provided. Methods include combined treatment with chemotherapeutic agents and anti-STn antibodies. Chemotherapy resistant ovarian cancer cells may be reduced. Chemotherapy resistant ovarian cancer cells may include cancer stem cells.
    Type: Application
    Filed: November 7, 2022
    Publication date: January 4, 2024
    Applicants: Seagen Inc., The General Hospital Corporation
    Inventors: David A. Eavarone, Jeffrey Behrens, Jillian M. Prendergast, Bo R. Rueda, Rosemary Foster, Kristen D. Starbuck
  • Compositions and Methods for Targeting Cancer Stem Cells
    Publication number: 20240003889
    Abstract: The present invention provides methods of testing anti-STn antibodies for their ability target cancer stem cells by isolating cancer stem cells from cultures, contacting them with anti-STn antibodies being tested, and measuring resulting cell viability.
    Type: Application
    Filed: November 7, 2022
    Publication date: January 4, 2024
    Applicants: Seagen Inc., The General Hospital Corporation
    Inventors: David A. Eavarone, Julie DeSander, Jeffrey Behrens, Bo R. Rueda, Rosemary Foster, Kristen D. Starbuck
  • Compositions and Methods for Targeting Cancer Stem Cells
    Publication number: 20230022411
    Abstract: The present invention provides methods of testing anti-STn antibodies for their ability target cancer stem cells by isolating cancer stem cells from cultures, contacting them with anti-STn antibodies being tested, and measuring resulting cell viability.
    Type: Application
    Filed: March 16, 2022
    Publication date: January 26, 2023
    Applicants: Seagen Inc., The General Hospital Corporation
    Inventors: David A. Eavarone, Julie DeSander, Jeffrey Behrens, Bo R. Rueda, Rosemary Foster, Kristen D. Starbuck
  • Compositions and Methods for Targeting Cancer Stem Cells
    Publication number: 20230029085
    Abstract: Compositions and methods for treating ovarian cancer are provided. Methods include combined treatment with chemotherapeutic agents and anti-STn antibodies. Chemotherapy resistant ovarian cancer cells may be reduced. Chemotherapy resistant ovarian cancer cells may include cancer stem cells.
    Type: Application
    Filed: March 16, 2022
    Publication date: January 26, 2023
    Applicants: Seagen Inc., The General Hospital Corporation
    Inventors: David A. Eavarone, Jeffrey Behrens, Jillian M. Prendergast, Bo R. Rueda, Rosemary Foster, Kristen D. Starbuck
  • COMPOSITIONS AND METHODS FOR TARGETING CANCER STEM CELLS
    Publication number: 20200041517
    Abstract: The present invention provides methods of testing anti-STn antibodies for their ability target cancer stem cells by isolating cancer stem cells from cultures, contacting them with anti-STn antibodies being tested, and measuring resulting cell viability.
    Type: Application
    Filed: June 10, 2016
    Publication date: February 6, 2020
    Applicants: Seattle Genetics, Inc., The General Hospital Corporation
    Inventors: David A. EAVARONE, Julie DeSANDER, Jeffrey BEHRENS, Bo R. RUEDA, Rosemary FOSTER, Kristen D. STARBUCK
  • COMPOSITIONS AND METHODS FOR TARGETING CANCER STEM CELLS
    Publication number: 20190031780
    Abstract: Compositions and methods for treating ovarian cancer are provided. Methods include combined treatment with chemotherapeutic agents and anti-STn antibodies. Chemotherapy resistant ovarian cancer cells may be reduced. Chemotherapy resistant ovarian cancer cells may include cancer stem cells.
    Type: Application
    Filed: January 27, 2017
    Publication date: January 31, 2019
    Inventors: David A. Eavarone, Jeffrey Behrens, Jillian M. Prendergast, Bo R. Rueda, Rosemary Foster, Kristen D. Starbuck
  • Methods for enhancing, improving, or increasing fertility or reproductive function
    Patent number: 9295662
    Abstract: The present disclosure is directed to methods for enhancing, improving or increasing fertility or reproductive function. For example, the present disclosure is directed to a method for enhancing, improving, or increasing a female human's likelihood of becoming pregnant comprising: administering to the human a nutritional, dietary, or food fatty acid supplement comprising: at least 30% docosahexaenoic acid (DHA), by weight of the total fatty acids in the supplement in a form chosen from ethyl ester, free fatty acid, and triglyceride.
    Type: Grant
    Filed: March 7, 2013
    Date of Patent: March 29, 2016
    Assignees: Children's Medical Center Corporation, The General Hospital Corporation
    Inventors: Mark Puder, Deepika Nehra, Bo R. Rueda
  • METHODS FOR ENHANCING, IMPROVING, OR INCREASING FERTILITY OR REPRODUCTIVE FUNCTION
    Publication number: 20150025048
    Abstract: The present disclosure is directed to methods for enhancing, improving or increasing fertility or reproductive function. For example, the present disclosure is directed to a method for enhancing, improving, or increasing a female human's likelihood of becoming pregnant comprising: administering to the human a nutritional, dietary, or food fatty acid supplement comprising: at least 30% docosahexaenoic acid (DHA), by weight of the total fatty acids in the supplement in a form chosen from ethyl ester, free fatty acid, and triglyceride.
    Type: Application
    Filed: March 7, 2013
    Publication date: January 22, 2015
    Inventors: Mark Puder, Deepika Nehra, Bo R. Rueda
  • Diagnosing, treating, and preventing cancer using cables
    Publication number: 20030109443
    Abstract: Disclosed herein is are methods of diagnosing, methods for determining the prognosis for treatment of, and methods for identifying candidate compounds for treating, stabilizing, or preventing cancer, for example, endometrial cancer. These methods utilize the novel tumor suppressor protein, Cables.
    Type: Application
    Filed: October 1, 2002
    Publication date: June 12, 2003
    Inventors: Bo R. Rueda, Lawrence R. Zukerberg, Chin-Lee Wu